For IPO Boutique's "scale of 1 to 5" BUY rating on Rigel Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
About Rigel Pharmaceuticals (adapted from Rigel Pharmaceuticals prospectus): Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.
This description is adapted from Rigel RIGL prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Rigel RIGL "RIGL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
